Aclaris Therapeutics, Inc. (ACRS)

NASDAQ: ACRS · IEX Real-Time Price · USD

1.05

-0.02 (-1.87%)

At close: Dec 29, 2023, 4:00 PM

1.08

+0.03 (2.86%)

After-hours: Dec 29, 2023, 7:57 PM EST

Income Statement (Annual)

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013
Revenue	29.75	6.76	6.48	4.23	6.15	1.68	0	0	0	0
Revenue Growth (YoY)	340.05%	4.30%	53.35%	-31.28%	265.48%	-	-	-	-	-
Cost of Revenue	11.96	4.71	5.13	4.06	4.33	1.21	0	0	0	0
Gross Profit	17.79	2.05	1.35	0.17	1.82	0.48	0	0	0	0
Selling, General & Admin	25.13	23.62	20.53	27.83	25.76	19.03	15.09	5.33	2.03	1.77
Research & Development	77.81	43.81	29.34	64.17	60.84	35.8	33.48	15.34	6.51	3.49
Other Operating Expenses	0	0	0	18.5	0	0	0	0	0	0
Operating Expenses	102.95	67.43	49.87	110.5	86.6	54.84	48.57	20.67	8.53	5.26
Operating Income	-85.15	-65.38	-48.52	-110.32	-84.78	-54.36	-48.57	-20.67	-8.53	-5.26
Other Expense / Income	1.75	25.48	2.68	51.03	47.96	15.99	-0.49	-0.1	-0.02	-0.02
Pretax Income	-86.91	-90.87	-51.2	-161.35	-132.74	-70.35	-48.08	-20.56	-8.52	-5.24
Income Tax	0	0	-0.18	0	0	-1.83	0	0	0	0
Net Income	-86.91	-90.87	-51.02	-161.35	-132.74	-68.52	-48.08	-20.56	-8.52	-5.24
Preferred Dividends	0	0	0	0	0	0	0	2.57	2.05	1.74
Net Income Common	-86.91	-90.87	-51.02	-161.35	-132.74	-68.52	-48.08	-23.13	-10.57	-6.98
Shares Outstanding (Basic)	65	57	43	41	33	28	21	6	2	1
Shares Outstanding (Diluted)	65	57	43	41	33	28	21	6	2	1
Shares Change	14.95%	33.36%	2.94%	25.57%	17.11%	31.22%	250.67%	255.04%	59.07%	-
EPS (Basic)	-1.33	-1.60	-1.20	-3.90	-4.03	-2.44	-2.25	-3.79	-6.15	-6.45
EPS (Diluted)	-1.33	-1.60	-1.20	-3.90	-4.03	-2.44	-2.25	-3.79	-6.15	-6.45
Free Cash Flow	-68.17	-52.44	-39.09	-98.06	-102.17	-55.9	-34.84	-20.88	-8.05	-4.92
Free Cash Flow Per Share	-1.04	-0.92	-0.92	-2.37	-3.10	-1.99	-1.63	-3.42	-4.68	-4.55
Gross Margin	59.80%	30.29%	20.81%	4.07%	29.62%	28.28%	-	-	-	-
Operating Margin	-286.21%	-967.08%	-748.52%	-2609.98%	-1378.31%	-3230.01%	-	-	-	-
Profit Margin	-292.11%	-1343.96%	-787.03%	-3817.22%	-2157.99%	-4071.48%	-	-	-	-
Free Cash Flow Margin	-229.13%	-775.65%	-602.99%	-2319.80%	-1660.98%	-3321.33%	-	-	-	-
EBITDA	-86.11	-89.94	-49.87	-154.95	-130.86	-69.95	-47.96	-20.47	-8.51	-5.23
EBITDA Margin	-289.43%	-1330.31%	-769.41%	-3665.60%	-2127.44%	-4156.33%	-	-	-	-
Depreciation & Amortization	0.8	0.92	1.32	6.41	1.88	0.4	0.12	0.09	0.01	0.01
EBIT	-86.91	-90.87	-51.2	-161.35	-132.74	-70.35	-48.08	-20.56	-8.52	-5.24
EBIT Margin	-292.11%	-1343.96%	-789.83%	-3817.22%	-2157.99%	-4180.21%	-	-	-	-

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).